Clinical Trials Browser

Interventional × Has results × Dalteparin × Clear all

Venous Thromboembolism

NCT00942968 2024-04-18

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Phase 4 Completed

338 enrolled 21 charts

Tumor-Agnostic

Neoplasms

NCT02744092 2023-10-03

CANVAS

Phase NA Completed

811 enrolled 19 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT00525057 2021-01-22

Dalteparin in Preventing DVT in Participants With Cancer

Phase NA Completed

65 enrolled 14 charts

LymphoidPlasma cellSarcoma

Bone Neoplasms, Femoral Fractures, Fractures, Spontaneous, Lymphoma, Multiple Myeloma, Neoplasm Metastasis, Sarcoma

NCT02585713 2020-08-04

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Phase 3 Completed

300 enrolled 11 charts

Classical hematology

Neoplasm Metastasis, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Intracranial Thrombosis, Venous Thromboembolism, Mesenteric Ischemia

NCT00952380 2019-04-16

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Phase 2 Completed

38 enrolled 30 charts

Classical hematology

Venous Thromboembolism

NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

Phase 3 Completed

1,046 enrolled 24 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT00966277 2016-12-12

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Phase 4 Completed

87 enrolled 9 charts

Classical hematologyGastrointestinal

Pancreatic Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT00876915 2015-11-24

PHACS

Phase 3 Terminated

218 enrolled 20 charts

Classical hematology

Pulmonary Embolism, Venous Thromboembolism

Clinical Trials

CARAVAGGIO

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

CANVAS

Dalteparin in Preventing DVT in Participants With Cancer

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Cancer Venous Thromboembolism (VTE)

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

PHACS